Cancer Medicines Forum workshop: April 2024

• Date:
  Friday, 05 April 2024, 13:00 (CEST) - 18:00 (CEST)
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands
  Live Broadcast

Event summary

The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are co-chairing the Cancer Medicines Forum (CMF) which objective is to integrate the work of the academic sector into the regulatory decision-making process by acting as an unique channel between the regulator and academic clinical research.

The deliverables of the CMF are aimed at supporting policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.

The CMF will be reporting its observations and preliminary solutions to address treatment optimisation at a hybrid workshop to be held at the EMA on 5th April 2024 under the Auspices of the EU Belgian Presidency. 

Video recording

Documents

Agenda - Cancer Medicines Forum - a way forward for treatment optimisation

Presentation - Cancer Medicines Forum - rationale and achievements (D. Lacombe, EORTC)

Presentation - Cancer Medicines Forum - de-escalating immunotherapy: the example of MOIO phase III French clinical trial (I. Korakis, IUCT-Oncoploe Toulouse & G. Gravis, Institut Paoli-Calmettes Marseille)

Presentation - Cancer Medicines Forum - EORTC, Unicancer, GETUG, CTI consortium trial (B. Tombal, EORTC)

Presentation - Cancer Medicines Forum - examples of drug development and optimisation in haematology (M. Kaiser, EHA)

Presentation - Cancer Medicines Forum - policy context (R. Sullivan, Institute of Cancer Policy, King's College London)

Presentation - Cancer Medicines Forum - treatment optimisation framework (C. Voltz-Girolt, EMA)

Presentation - Cancer Medicines Forum - cancer drug development - as a public health matter? (C. Booth, Queen's University, Kingston, Canada)

Presentation - Cancer Medicines Forum - the global challenges of post-market optimization research (D. Goldstein, Tel Aviv University)

Presentation - Cancer Medicines Forum - innovative evidence generation: OCE project Pragmatica (D. R. Rivera, FDA)

Presentation - Cancer Medicines Forum - the added value of treatment optimization: how does it apply to other fields of medicine? (G. Brusselle, Ghent University Hospital, Belgium)